Generic-drug firms praise biogenerics proposal in Obama's budget

In his 2010 budget, President Barack Obama is proposing a more efficient process for approving generic biotech drugs, a move that won praise from generic-drug companies. The process would "mean huge savings for payers and insurance companies, patients, and state and local governments" and even federal programs, said Kathleen Jaeger, CEO of the Generic Pharmaceutical Association.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX